i J., Ali M., Baboota S., Sahni JK, Ramassamy C., Dao L., Bhavna. Potential of nanoparticulate drug delivery systems by intranasal administration / / Curr. Pharm. Design. 2010. Vol. 16. P. 1644-1653.
. Bali V., Singh S., Kumar A. Nanomedicines for nasal drug delivery / / Patenting Nanomedicines: Legal Aspects, Intellectual Property and Grant Opportunities. Ed.: Souto E.B. Springer, 2012. P. 251-275.
. Cheng C., Zhang X., Xiang J., Wang Y., Zheng C., Lu Z., Li C. Development of novel selfassembled poly (3acrylamidophenylboronic acid) / poly (2lactobionamidoethyl methacrylate) hybrid nanoparticles for improving nasal adsorption of insulin// Soft Matter. 2012. Vol. 8. P. 765-773.
. Feng X., Cheng Y., Yang K., Zhang J., Wu Q., Xu T. Hostguest сhemistry of dendrimerdrug complexes. 5. Insights into the design of formulations for noninvasive delivery of heparin revealed by isothermal titration calorimetry and NMR studies / / J. Phys. Chem. B. 2010. Vol. 114. P. 11017-11026.
17. Jintapattanakit A., Peungvicha P., Sailasuta A., Kissel T., Junyaprasert VB Nasal absorption and local tissue reaction of insulin nanocomplexes of trimethyl chitosan derivatives in rats / / J. Pharm. Pharmacol. 2010. Vol. 62. P. 583-591.
. Krti L., Kukovecz T., Kozma G., Ambrus R., Deli MA, Szab (R) v) sz P. Study of the parameters influencing the cogrinding process for the production of meloxicam nanoparticles / / Powder Technol. 2011. Vol. 212. P. 210 - 217.
. Lai SK, Suk JS, Pace A., Wang YY, Yang M., Mert O., Chen J., Kim J., Hanes J. Drug carrier nanoparticles that penetrate human chronic rhinosinusitis mucus / / Biomaterials. 2011. Vol. 32. P. 6285-6290.
. Mainardes RM, Khalil NM, Daflon Gremico MP Intranasal delivery of zidovudine by PLA and PLAPEG blend nanoparticles / / Int. J. Pharm. 2010. Vol. 395. P. 266-271.
. McDonough J., Dixon H., Ladika M. Nasal delivery of microand nanoencapsulated drugs / / Handbook of NonInvasive Drug Delivery Systems. Ed.: Kulkarni VS Elsevier, 2010. P. 193-208.
. Petkar KC, Chavhan SS, AgatonovikKustrin S., Sawant KK Nanostructured materials in drug and gene delivery: a review of the state of the art / / Crit. Rev. Ther. Drug. Carrier. Syst. 2011. Vol. 28. P. 101-164.
. Prego C., Goycoolea FM Nanostructures overcoming the nasal barrier: protein and peptide delivery strategies / / Nanostructured Biomaterials for Overcoming Biological Barriers. Eds: Alonso M J., Csaba NS. Royal Society of Chemistry, 2012. P. 133-155.
24. Qiang F., Shin H.J., Lee B.J., Han H.K. Enhanced systemic exposure of fexofenadine via the intranasal administration of chitosancoated liposome / / Int. J. Pharm. 2012. Vol. 430. P. 161-166.
. Shahnaz G., Vetter A., ??Barthelmes J., Rahmat D., Laffleur F., Iqbal J., Perera G., Schlocker W., Dnnhaput S., Augustijns P., BernkopSchn rch A. Thiolated chitosan nanoparticles for the nasal administration of leuprolide: Bioavailability and pharmacokinetic characterization / / Int. J. Pharm. 2012. Vol. 428. P. 164-170.
. Vllasaliu D., ExpositoHarris R., Heras A., Casettari L., Garnett M., Illum L., Stolnik S. Tight junction modulation by chitosan nanopa...
